<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">32886252</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>18</Day></DateCompleted><DateRevised><Year>2021</Year><Month>06</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1459</ISSN><JournalIssue CitedMedium="Internet"><Volume>268</Volume><Issue>3</Issue><PubDate><Year>2021</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Journal of neurology</Title><ISOAbbreviation>J Neurol</ISOAbbreviation></Journal><ArticleTitle>Manifold learning for amyotrophic lateral sclerosis functional loss assessment : Development and validation of a prognosis model.</ArticleTitle><Pagination><StartPage>825</StartPage><EndPage>850</EndPage><MedlinePgn>825-850</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00415-020-10181-2</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is an inexorably progressive neurodegenerative condition with no effective disease-modifying therapy at present. Given the striking clinical heterogeneity of the condition, the development and validation of reliable prognostic models is a recognised research priority. We present a prognostic model for functional decline in ALS where outcome uncertainty is taken into account. Patient data were reduced and projected onto a 2D space using Uniform Manifold Approximation and Projection (UMAP), a novel non-linear dimension reduction technique. Information from 3756 patients was included. Development data were sourced from past clinical trials. Real-world population data were used as validation data. Predictors included age, gender, region of onset, symptom duration, weight at baseline, functional impairment, and estimated rate of functional loss. UMAP projection of patients showed an informative 2D data distribution. As limited data availability precluded complex model designs, the projection was divided into three zones defined by a functional impairment range probability. Zone membership allowed individual patient prediction. Patients belonging to the first zone had a probability of [Formula: see text] (&#xb1; [Formula: see text]) to have an ALSFRS score over 20 at 1-year follow-up. Patients within the second zone had a probability of [Formula: see text] (&#xb1; [Formula: see text]) to have an ALSFRS score between 10 and 30 at 1&#xa0;year follow-up. Finally, patients within the third zone had a probability of [Formula: see text] (&#xb1; [Formula: see text]) to have an ALSFRS score lower than 20 at 1&#xa0;year follow-up. This approach requires a limited set of features, is easily updated, improves with additional patient data, and accounts for results uncertainty. This method could therefore be used in a clinical setting for patient stratification and outcome projection.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Grollemund</LastName><ForeName>Vincent</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>LIP6, Sorbonne Universit&#xe9;, Paris, France. vincent.grollemund@lip6.fr.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>FRS Consulting, Paris, France. vincent.grollemund@lip6.fr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Le Chat</LastName><ForeName>Ga&#xe9;tan</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>FRS Consulting, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Secchi-Buhour</LastName><ForeName>Marie-Sonia</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>FRS Consulting, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delbot</LastName><ForeName>Fran&#xe7;ois</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>LIP6, Sorbonne Universit&#xe9;, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Modal'X, Nanterre Universit&#xe9;, Nanterre, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pradat-Peyre</LastName><ForeName>Jean-Fran&#xe7;ois</ForeName><Initials>JF</Initials><AffiliationInfo><Affiliation>LIP6, Sorbonne Universit&#xe9;, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Modal'X, Nanterre Universit&#xe9;, Nanterre, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bede</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Laboratoire d'Imagerie Biom&#xe9;dicale, Sorbonne Universit&#xe9;, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>D&#xe9;partement de Neurologie, Piti&#xe9;-Salp&#xea;tri&#xe8;re University Hospital, APHP, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Computational Neuroimaging Group, Trinity College, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pradat</LastName><ForeName>Pierre-Fran&#xe7;ois</ForeName><Initials>PF</Initials><AffiliationInfo><Affiliation>Laboratoire d'Imagerie Biom&#xe9;dicale, Sorbonne Universit&#xe9;, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>D&#xe9;partement de Neurologie, Piti&#xe9;-Salp&#xea;tri&#xe8;re University Hospital, APHP, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Northern Ireland Center for Stratified Medecine, Biomedical Sciences Research Institute Ulster University, Londonderry, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2017/1051</GrantID><Agency>MESRI grant CIFRE</Agency><Country/></Grant><Grant><GrantID>EIA-2017-2019</GrantID><Agency>Health Research Board (Ireland)</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>09</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>J Neurol</MedlineTA><NlmUniqueID>0423161</NlmUniqueID><ISSNLinking>0340-5354</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">Manifold learning</Keyword><Keyword MajorTopicYN="N">Non-linear dimension reduction</Keyword><Keyword MajorTopicYN="N">Prognosis</Keyword><Keyword MajorTopicYN="N">UMAP</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>6</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>8</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>8</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>9</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>9</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32886252</ArticleId><ArticleId IdType="doi">10.1007/s00415-020-10181-2</ArticleId><ArticleId IdType="pii">10.1007/s00415-020-10181-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Robberecht W, Philips T (2013) The changing scene of amyotrophic lateral sclerosis. Nat Rev Neurosci 14(4):248&#x2013;264. https://doi.org/10.1038/nrn3430</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn3430</ArticleId><ArticleId IdType="pubmed">23463272</ArticleId></ArticleIdList></Reference><Reference><Citation>Finegan E, Chipika RH, Shing SLH, Hardiman O, Bede P (2019) Primary lateral sclerosis: a distinct entity or part of the ALS spectrum? Amyotrophic Lateral Scler Frontotemporal Degener 20(3&#x2013;4):133&#x2013;145. https://doi.org/10.1080/21678421.2018.1550518</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2018.1550518</ArticleId></ArticleIdList></Reference><Reference><Citation>Swinnen B, Robberecht W (2014) The phenotypic variability of amyotrophic lateral sclerosis. Nat Rev Neurol 10(11):661&#x2013;670. https://doi.org/10.1038/nrneurol.2014.184</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2014.184</ArticleId><ArticleId IdType="pubmed">25311585</ArticleId></ArticleIdList></Reference><Reference><Citation>Hiroshi M, Brooks Benjamin R, Vincenzo S (2014) Clinical trials in amyotrophic lateral sclerosis: why so many negative trials and how can trials be improved? Lancet Neurol 13(11):1127&#x2013;1138. https://doi.org/10.1016/s1474-4422(14)70129-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1474-4422(14)70129-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Elamin M, Bede P, Montuschi A, Pender N, Chio A, Hardiman O (2015) Predicting prognosis in amyotrophic lateral sclerosis: a simple algorithm. J Neurol 262(6):1447&#x2013;1454. https://doi.org/10.1007/s00415-015-7731-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-015-7731-6</ArticleId><ArticleId IdType="pubmed">25860344</ArticleId><ArticleId IdType="pmc">4469087</ArticleId></ArticleIdList></Reference><Reference><Citation>Adriano C, Giancarlo L, Orla H, Robert S, Douglas M, Ettore B, Traynor Bryan G (2009) On behalf of the Eurals Consortium. Prognostic factors in ALS: a critical review. Amyotrophic Lateral Scler 10(5&#x2013;6):310&#x2013;323. https://doi.org/10.3109/17482960802566824</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482960802566824</ArticleId></ArticleIdList></Reference><Reference><Citation>Elamin M, Phukan J, Bede P, Jordan N, Byrne S, Pender N, Hardiman O (2011) Executive dysfunction is a negative prognostic indicator in patients with ALS without dementia. Neurology 76(14):1263&#x2013;1269. https://doi.org/10.1212/wnl.0b013e318214359f</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.0b013e318214359f</ArticleId><ArticleId IdType="pubmed">21464431</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon PH, Salachas F, Lacomblez L, Le Forestier N, Pradat P-F, Bruneteau G, Elbaz A, Meininger V (2012) Predicting survival of patients with amyotrophic lateral sclerosis at presentation: a 15-year experience. Neurodegenerat Dis 12(2):81&#x2013;90. https://doi.org/10.1159/000341316</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000341316</ArticleId></ArticleIdList></Reference><Reference><Citation>Joachim W, Anton S, Whrle Johannes C, Frederick P, Nix Wilfred A, Matthias M, Grau Armin J (2014) Factors predicting one-year mortality in amyotrophic lateral sclerosis patients&#x2014;data from a population-based registry. BMC Neurol. https://doi.org/10.1186/s12883-014-0197-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12883-014-0197-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent G, Pierre-Fran&#xe7;ois P, Giorgia Q, Fran&#xe7;ois D, Ga&#xe9;tan LC, Jean-Fran&#xe7;ois P-P, Peter B (2019) Machine learning in amyotrophic lateral sclerosis: achievements, pitfalls, and future directions. Front Neurosci. https://doi.org/10.3389/fnins.2019.00135</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00135</ArticleId><ArticleId IdType="pubmed">31998060</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhengnan H, Hongjiu Z, Jonathan B, Goutman Stephen A, Bhramar M, Dinov Ivo D, Yuanfang G et al (2017) Complete hazard ranking to analyze right-censored data: an als survival study. PLoS Comput Biol 13(12):e1005887</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pcbi.1005887</ArticleId></ArticleIdList></Reference><Reference><Citation>Beaulieu-Jones Brett K, Greene CS et al (2016) Semi-supervised learning of the electronic health record for phenotype stratification. J Biomed Inf 64:168&#x2013;178</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2016.10.007</ArticleId></ArticleIdList></Reference><Reference><Citation>Christina S, Orla H, Peter B (2017) Survival prediction in amyotrophic lateral sclerosis based on MRI measures and clinical characteristics. BMC Neurol. https://doi.org/10.1186/s12883-017-0854-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12883-017-0854-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Henk-Jan W, Debray Thomas PA, Visser Anne E, van Eijk RPA, Rooney James PK, Andrea C, Sarah M, McDermott Christopher J, Thompson Alexander G, Susana P, Xenia K, Angela R, Beatrice S, Helma S, Middelkoop Bas M, Dekker Annelot M, van Vugt JJFA, van Rheenen W, Vajda A, Heverin M, Kazoka M, Hollinger H, Gromicho M, Krner S, Ringer Thomas M, Rdiger A, Gunkel A, Shaw Christopher E, Bredenoord Annelien L, van Es Michael A, Corcia P, Couratier P, Weber M, Grosskreutz J, Ludolph Albert C, Petri S, de Carvalho M, Van Damme P, Talbot K, Turner Martin R, Shaw Pamela J, Al-Chalabi A, Chi&#xf2; A, Hardiman O, Moons Karel GM, Veldink Jan H, van den Berg Leonard H, (2018) Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model. Lancet Neurol 17(5):423&#x2013;433. https://doi.org/10.1016/s1474-4422(18)30089-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1474-4422(18)30089-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Mei-Lyn O, Fang TP, Holbrook Joanna D (2017) Predicting functional decline and survival in amyotrophic lateral sclerosis. PLoS ONE 12(4):e0174925</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0174925</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor Albert A, Christina F, Meraida P, Liuxia W, Neta Z, Mike K, Glass Jonathan D, Ennist David L (2016) Predicting disease progression in amyotrophic lateral sclerosis. Ann Clin Trans Neurol 3(11):866&#x2013;875. https://doi.org/10.1002/acn3.348</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.348</ArticleId></ArticleIdList></Reference><Reference><Citation>Hothorn T, Jung HH (2014) RandomForest4life: a random forest for predicting ALS disease progression. Amyotrophic Lateral Scler Frontotemporal Degener 15(5&#x2013;6):444&#x2013;452. https://doi.org/10.3109/21678421.2014.893361</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2014.893361</ArticleId></ArticleIdList></Reference><Reference><Citation>Elamin M, Pinto-Grau M, Burke T, Bede P, Rooney J, O&#x2019;Sullivan M, Lonergan K, Kirby E, Quinlan E, Breen N, Vajda A, Heverin M, Pender N, Hardiman O (2016) Identifying behavioural changes in ALS: validation of the beaumont behavioural inventory (BBI). Amyotrophic Lateral Scler Frontotemporal Degener 18(1&#x2013;2):68&#x2013;73. https://doi.org/10.1080/21678421.2016.1248976</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2016.1248976</ArticleId></ArticleIdList></Reference><Reference><Citation>Hannah CR, Eoin F, Stacey LHS, Orla H, Peter B, (mar, (2019) Tracking a fast-moving disease: longitudinal markers, monitoring, and clinical trial endpoints in ALS. Front Neurol. https://doi.org/10.3389/fneur.2019.00229</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.00229</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede P, Hardiman O (2017) Longitudinal structural changes in ALS: a three time-point imaging study of white and gray matter degeneration. Amyotrophic Lateral Scler Frontotemporal Degener 19(3&#x2013;4):232&#x2013;241. https://doi.org/10.1080/21678421.2017.1407795</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2017.1407795</ArticleId></ArticleIdList></Reference><Reference><Citation>Cedarbaum JM, Stambler N (1997) Performance of the amyotrophic lateral sclerosis functional rating scale (ALSFRS) in multicenter clinical trials. J Neurol Sci 152:s1&#x2013;s9. https://doi.org/10.1016/s0022-510x(97)00237-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0022-510x(97)00237-2</ArticleId><ArticleId IdType="pubmed">9419047</ArticleId></ArticleIdList></Reference><Reference><Citation>Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, Nakanishi A (1999) The ALSFRS-r: a revised ALS functional rating scale that incorporates assessments of respiratory function. J Neurol Sci 169(1&#x2013;2):13&#x2013;21. https://doi.org/10.1016/s0022-510x(99)00210-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0022-510x(99)00210-5</ArticleId><ArticleId IdType="pubmed">10540002</ArticleId></ArticleIdList></Reference><Reference><Citation>Roche Jose C, Ricardo R-G, Scott Kirsten M, William S, Ellis Catherine E, Rachel B, Lokesh W, Turner Martin R, Nigel LP, Shaw Christopher E et al (2012) A proposed staging system for amyotrophic lateral sclerosis. Brain 135(3):847&#x2013;852</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr351</ArticleId></ArticleIdList></Reference><Reference><Citation>Adriano C, Hammond Edward R, Gabriele M, Virginio B, Graziella F (2013) Development and evaluation of a clinical staging system for amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 86(1):38&#x2013;44</Citation></Reference><Reference><Citation>Thakore Nimish J, Lapin Brittany R, Kinzy Tyler G, Pioro Erik P (2018) Deconstructing progression of amyotrophic lateral sclerosis in stages: a markov modeling approach. Amyotrophic Lateral Scler Frontotemporal Degener 19(7&#x2013;8):483&#x2013;494</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2018.1484925</ArticleId></ArticleIdList></Reference><Reference><Citation>Ton F, Al KA, Stahl Daniel R, La Torre L, Claudia MC, Carolyn Y, Shaw Pamela J, Nigel LP, Ammar A-C (2017) Comparison of the king&#x2019;s and MiToS staging systems for ALS. Amyotrophic Lateral Sclerosis Frontotemporal Degener 18(3&#x2013;4):227&#x2013;232. https://doi.org/10.1080/21678421.2016.1265565</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2016.1265565</ArticleId></ArticleIdList></Reference><Reference><Citation>Alessandro Z, Rosario V, Adriano C, Di CB, (apr, (2019) A dynamic bayesian network model for the simulation of amyotrophic lateral sclerosis progression. BMC Bioinf. https://doi.org/10.1186/s12859-019-2692-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12859-019-2692-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Ton F, Ahmad AK, Jacques-Henri M, Ashley J, Nigel LP, Gilbert B, Ammar A-C (2018) Stage at which riluzole treatment prolongs survival in patients with amyotrophic lateral sclerosis: a retrospective analysis of data from a dose-ranging study. Lancet Neurol 17(5):416&#x2013;422</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(18)30054-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Taguchi Y, Iwadate M, Umeyama H (2015) Heuristic principal component analysis-based unsupervised feature extraction and its application to gene expression analysis of amyotrophic lateral sclerosis data sets. In 2015 IEEE Conference on Computational Intelligence in Bioinformatics and Computational Biology (CIBCB). IEEE. https://doi.org/10.1109/cibcb.2015.7300274</Citation></Reference><Reference><Citation>Ming T, Chao G, Goutman Stephen A, Alexandr K, Bhramar M, Yuanfang G, Dinov Ivo D (2019) Model-based and model-free techniques for amyotrophic lateral sclerosis diagnostic prediction and patient clustering. Neuroinformatics 17(3):407&#x2013;421</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12021-018-9406-9</ArticleId></ArticleIdList></Reference><Reference><Citation>McInnes L, Healy J, Melville J (2018) Umap: Uniform manifold approximation and projection for dimension reduction. arXiv preprint arXiv:1802.03426</Citation></Reference><Reference><Citation>Lenglet T, Lacomblez L, Abitbol JL, Ludolph A, Mora JS, Wim R, Shaw PJ, Pruss RM, Cuvier V, Meininger V et al (2014) A phase ii&#x2013;iii trial of olesoxime in subjects with amyotrophic lateral sclerosis. Eur J Neurol 21(3):529&#x2013;536</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.12344</ArticleId></ArticleIdList></Reference><Reference><Citation>Meininger V, Asselain B, Guillet P, Leigh PN, Ludolph A, Lacomblez L, Wim R et al (2006) Pentoxifylline in als: a double-blind, randomized, multicenter, placebo-controlled trial. Neurology 66(1):88&#x2013;92</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000191326.40772.62</ArticleId></ArticleIdList></Reference><Reference><Citation>PRO-ACT (2015) Pro-act database. https://nctu.partners.org/ProACT/Home/Index . Accessed: 2020 Jan 01</Citation></Reference><Reference><Citation>Rubika B, Ashley J, Naheed J, Catherine K, Ellis Catherine M, Rachel B, Turner Martin R, Nigel LP, Shaw Christopher E, Ammar A-C (2014) Estimating clinical stage of amyotrophic lateral sclerosis from the als functional rating scale. Amyotrophic Lateral Scler Frontotemporal Degener 15(3&#x2013;4):279&#x2013;284</Citation></Reference><Reference><Citation>Querin G, El Mendili MM, Lenglet T, Delphine S, Marchand-Pauvert V, Benali H, Pradat P-F (2017) Spinal cord multi-parametric magnetic resonance imaging for survival prediction in amyotrophic lateral sclerosis. Eur J Neurol 24(8):1040&#x2013;1046. https://doi.org/10.1111/ene.13329</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.13329</ArticleId><ArticleId IdType="pubmed">28586096</ArticleId></ArticleIdList></Reference><Reference><Citation>Hulley Stephen B, Cummings Steven R, Browner Warren S, Grady Deborah G, Newman Thomas B (2006) Designing clinical research. Lippincott Williams &amp; Wilkins, Philadelphia</Citation></Reference><Reference><Citation>Olney RK, Murphy J, Forshew D, Garwood E, Miller BL, Langmore S, Kohn MA, Lomen-Hoerth C (2005) The effects of executive and behavioral dysfunction on the course of ALS. Neurology 65(11):1774&#x2013;1777. https://doi.org/10.1212/01.wnl.0000188759.87240.8b</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000188759.87240.8b</ArticleId><ArticleId IdType="pubmed">16344521</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhouwei X, Rafea A, Alruwaili S, Frequency of abnormality and effect on survival, (2017) Robert David Henderson, and Pamela Ann McCombe Screening for cognitive and behavioural impairment in amyotrophic lateral sclerosis. J Neurol Sci 376:16&#x2013;23. https://doi.org/10.1016/j.jns.2017.02.061</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2017.02.061</ArticleId></ArticleIdList></Reference><Reference><Citation>Elamin M, Bede P, Byrne S, Jordan N, Gallagher L, Wynne B, O&#x2019;Brien C, Phukan J, Lynch C, Pender N, Hardiman O (2013) Cognitive changes predict functional decline in ALS: a population-based longitudinal study. Neurology 80(17):1590&#x2013;1597. https://doi.org/10.1212/wnl.0b013e31828f18ac</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.0b013e31828f18ac</ArticleId><ArticleId IdType="pubmed">23553481</ArticleId></ArticleIdList></Reference><Reference><Citation>Goutman Stephen&#xa0;A, Chen Kevin&#xa0;S, Paez-Colasante Ximena, Feldman Eva&#xa0;L (2018) Emerging understanding of the genotype&#x2013;phenotype relationship in amyotrophic lateral sclerosis. In: Neurogenetics, Part II, pages 603&#x2013;623. Elsevier, https://doi.org/10.1016/b978-0-444-64076-5.00039-9</Citation></Reference><Reference><Citation>Alice P, De ME, Andrea L, Giulia S, Elena C, Fabrizio R, Valeria S, Christian L (2019) The prognostic value of spirometric tests in amyotrophic lateral sclerosis patients. Clin Neurol Neurosurg 184:105456. https://doi.org/10.1016/j.clineuro.2019.105456</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clineuro.2019.105456</ArticleId></ArticleIdList></Reference><Reference><Citation>Tortelli R, Copetti M, Panza F, Fontana A, Cortese R, Capozzo R, Introna A, D&#x2019;Errico E, Zoccolella S, Arcuti S et al (2016) Time to generalization and prediction of survival in patients with amyotrophic lateral sclerosis: a retrospective observational study. Eur J Neurol 23(6):1117&#x2013;1125</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.12994</ArticleId></ArticleIdList></Reference><Reference><Citation>Moglia C, Calvo A, Grassano M, Canosa A, Manera U, D&#x2019;Ovidio F, Bombaci A, Bersano E, Mazzini L, Mora G, Chi&#xf2; A (2019) Early weight loss in amyotrophic lateral sclerosis: outcome relevance and clinical correlates in a population-based cohort. J Neurol Neurosurg Psychiatry 90(6):666&#x2013;673. https://doi.org/10.1136/jnnp-2018-319611</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2018-319611</ArticleId><ArticleId IdType="pubmed">30630957</ArticleId></ArticleIdList></Reference><Reference><Citation>Susan B, Marwa E, Peter B, Aleksey S, Cathal W, Bernie C, Mark H, Norah J, Kevin K, Catherine L, McLaughlin Russell L, Mahadeva IP, Caoimhe OB, Julie P, Brona W, Bokde Arun L, Bradley Daniel G, Niall P, Ammar A-C, Orla H (2012) Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a c9orf72 repeat expansion: a population-based cohort study. Lancet Neurol 11(3):232&#x2013;240. https://doi.org/10.1016/s1474-4422(12)70014-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1474-4422(12)70014-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Peter B, Iyer PM, Eoin F, Taha O, Orla H (2017) Virtual brain biopsies in amyotrophic lateral sclerosis: diagnostic classification based on in vivo pathological patterns. NeuroImage 15:653&#x2013;658. https://doi.org/10.1016/j.nicl.2017.06.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2017.06.010</ArticleId></ArticleIdList></Reference><Reference><Citation>Querin G, El Mendili M-M, Bede P, Delphine S, Lenglet T, Marchand-Pauvert V, Pradat P-F (2018) Multimodal spinal cord MRI offers accurate diagnostic classification in ALS. J Neurol Neurosurg Psychiatry 89(11):1220&#x2013;1221. https://doi.org/10.1136/jnnp-2017-317214</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2017-317214</ArticleId><ArticleId IdType="pubmed">29353238</ArticleId></ArticleIdList></Reference><Reference><Citation>Agosta F, Spinelli EG, Riva N, Fontana A, Basaia S, Canu E, Castelnovo V, Falzone Y, Carrera P, Comi G, Filippi M (2019) Survival prediction models in motor neuron disease. Eur J Neurol 26(9):1143&#x2013;1152. https://doi.org/10.1111/ene.13957</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.13957</ArticleId><ArticleId IdType="pubmed">30920076</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede P, Querin G, Pradat P-F (2018) The changing landscape of motor neuron disease imaging. Curr Opin Neurol 31(4):431&#x2013;438. https://doi.org/10.1097/wco.0000000000000569</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/wco.0000000000000569</ArticleId><ArticleId IdType="pubmed">29750730</ArticleId><ArticleId IdType="pmc">29750730</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins Gary S, Reitsma Johannes B, Altman Douglas G, Moons Karel GM (2015) Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (tripod): the tripod statement. BMC Med 13(1):1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-014-0241-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Quartagno M, Carpenter JR (2015) Multiple imputation for IPD meta-analysis: allowing for heterogeneity and studies with missing covariates. Stat Med 35(17):2938&#x2013;2954. https://doi.org/10.1002/sim.6837</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.6837</ArticleId><ArticleId IdType="pubmed">26681666</ArticleId><ArticleId IdType="pmc">5064632</ArticleId></ArticleIdList></Reference><Reference><Citation>Karl P (1901) Liii. on lines and planes of closest fit to systems of points in space. Lond Edinburgh Dublin Philos Maga J Sci 2(11):559&#x2013;572</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14786440109462720</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Maaten Laurens, Hinton Geoffrey, (2008) Visualizing data using t-sne. J Mach Learn Res 9:2579&#x2013;2605</Citation></Reference><Reference><Citation>Schubert Erich, Gertz Michael (2017) Intrinsic t-stochastic neighbor embedding for visualization and outlier detection. In: International Conference on Similarity Search and Applications, Springer, Berlin pp 188&#x2013;203</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>